Research and Markets has announced the addition of the "Bipolar Disorder" report to their offering.
Generic dominance will prevent the growth of the bipolar disorder market, and few pipeline candidates show promise to completely reverse this trend.
This report addresses the following questions:
- What are the key events shaping the bipolar disorder market dynamics over 2014-23? - Which segments of the market provide opportunities for growth? - How does the bipolar disorder pipeline compare to other psychiatric indications, and what are the candidates to look out for? - How do currently available bipolar disorder drugs compare to one another? - What is the standard of care in bipolar disorder, and which are the key unmet needs in treatment?